<DOC>
<DOCNO>
EP-0008652
</DOCNO>
<TEXT>
<DATE>
19800319
</DATE>
<IPC-CLASSIFICATIONS>
C07D-239/48 C07D-498/00 A61P-9/08 C07D-401/04 C07D-239/00 A61P-9/00 A61P-9/12 A61K-31/505 <main>C07D-401/04</main> C07D-498/04 C07D-401/00 
</IPC-CLASSIFICATIONS>
<TITLE>
new intermediates and their use for the preparation of new oxadiazolo-pyrimidine derivatives.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft <sep>
</APPLICANT>
<INVENTOR>
muller jean-claude dr<sep>ramuz henri dr<sep>muller, jean-claude, dr.<sep>ramuz, henri, dr.<sep>muller, jean-claude, dr.27 rue albert schweitzer parc d'entremontf-68170 rixheimfr<sep>ramuz, henri, dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>muller, jean-claude, dr. <sep>ramuz, henri, dr.<sep>muller, jean-claude, dr.27 rue albert schweitzer parc d'entremontf-68170 rixheimfr<sep>ramuz, henri, dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>
</INVENTOR>
<ABSTRACT>
The oxadiazolopyrimidine derivatives of the formula wherein R is alkyl or alkoxyalkyl, and their salts can be prepared by reacting a corresponding 2-amino-4 pyrimidin carbamate 3-oxide with phosgene and any salt formation.They have long-lasting valuable vascular and / or blood pressure-sensitive properties and are therefore suitable for the treatment of gamed hypertension or as vasodilators with peripheral circulatory disorders.
</ABSTRACT>
</TEXT>
</DOC>
